Edwards Lifesciences Corp (EW)vsOwlet Inc (OWLT)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
OWLT
Owlet Inc
$5.11
-2.48%
HEALTHCARE · Cap: $150.38M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 5640% more annual revenue ($6.07B vs $105.71M). EW leads profitability with a 17.7% profit margin vs -37.5%. EW earns a higher WallStSmart Score of 55/100 (C).
EW
Buy55
out of 100
Grade: C
OWLT
Avoid32
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Intrinsic value data unavailable for OWLT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Revenue surging 29.6% year-over-year
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -8.0% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : OWLT
The strongest argument for OWLT centers on Revenue Growth. Revenue growth of 29.6% demonstrates continued momentum.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : OWLT
The primary concerns for OWLT are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
EW profiles as a mature stock while OWLT is a growth play — different risk/reward profiles.
OWLT carries more volatility with a beta of 1.74 — expect wider price swings.
OWLT is growing revenue faster at 29.6% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Bottom Line
EW scores higher overall (55/100 vs 32/100), backed by strong 17.7% margins and 13.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Owlet Inc
HEALTHCARE · MEDICAL DEVICES · USA
Owlet Inc. is a pioneering leader in infant health technology, dedicated to improving the safety and well-being of newborns through innovative monitoring solutions. Its flagship product, the Owlet Smart Sock, utilizes advanced pulse oximetry to provide continuous tracking of infants' heart rates and oxygen levels, offering critical health insights directly to parents' mobile devices. As the demand for pediatric health monitoring continues to rise, Owlet is well-equipped to expand its product offerings and enhance its market position in the rapidly evolving infant health sector. By prioritizing actionable data for parents and advancing pediatric care, Owlet is establishing a significant presence at the convergence of healthcare and technology.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?